The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; Novartis; Roche
Research Funding - Merck Serono (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; GlaxoSmithKline; Novartis
De-escalated treatment with trastuzumab-pertuzumab-letrozole in patients with HR+/HER2+ operable breast cancer with Ki67 response after 2 weeks letrozole: Final results of the PerELISA neoadjuvant study.
 
Valentina Guarneri
Consulting or Advisory Role - Lilly
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene
 
Maria Vittoria Dieci
Travel, Accommodations, Expenses - Celgene; Genomic Health
 
Giancarlo Bisagni
No Relationships to Disclose
 
Antonio Frassoldati
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Roche
 
Giulia Valeria Bianchi
No Relationships to Disclose
 
Gian Luca De Salvo
Travel, Accommodations, Expenses - Bayer
 
Enrico Orvieto
No Relationships to Disclose
 
Matteo Curtarello
No Relationships to Disclose
 
Tomás Pascual
No Relationships to Disclose
 
Laia Pare
No Relationships to Disclose
 
Massimo Ambroggi
No Relationships to Disclose
 
Carlo Alberto Giorgi
Employment - Baxter (I)
Travel, Accommodations, Expenses - Celgene
 
Gabriella Moretti
No Relationships to Disclose
 
Gaia Griguolo
No Relationships to Disclose
 
Roberto Vicini
No Relationships to Disclose
 
Aleix Prat
Consulting or Advisory Role - NanoString Technologies (Inst)
Research Funding - NanoString Technologies (Inst)
 
Pier Franco Conte
Speakers' Bureau - AstraZeneca; Novartis; Roche/Genentech
Research Funding - Merck Serono (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Novartis